β Scribed by Stewart, F.E.
No coin nor oath required. For personal study only.
Ind.
RIZPOIZT OF THE COMMITTEE ON PATENTS AND TRADEMARKS.* BY F. E. STEWART, CHAIRMAN. The special object of this report is to call attention to the proceedings of the American Therapeutic Society and the Pennsylvania Pharmaceutical Association working in co8peration with the chairman of your committee for correcting certain abuses of the patent and trademark laws and the effects of this abuse upon the practice of pharmacy and medicine.
The American Therapeutic Society was organized in 1900, during the meeting of the Pharmaeopmial Convcntion at Washington, to promote progress in therapeutics and stem the rapidly growing therapeutic nihilism in regard to drugs as remedies for disease. Among the causes of this loss of faith in drugs it was discovered that the growth of surgical specialties is gradually forcing the teaching of therapeutics out of the medical schools and colleges. Accordingly, a t the last annual meeting, May 1-2, 1922, held in Washington, the report of acommittee outlining a typical curriculum for the restoration of therapeutic teaching was adopted for the use of these institutions. I t was also found that the introduction of alleged new remedies by misleading advertising in the medical journals is an important factor in the loss of faith in drugs; also that the patent and trademark laws are misinterpreted and misapplied for the protection of this objectionable "new remedy" business. The following resolutions were adopted by the American Therapeutic Society to aid in correcting these abuses and approvcd by the Pennsylvania Pharmaceutical Association at its recent annual meeting held a t Buena Vista Springs, June 20-22, 1922. This report should be read in connection with a paper contributed to the Scientific Section entitled "Pharmaceutical Institutions," appearing on page 129 of this number of the JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION.
Preamble and Resolutions Adopted by the American Therapeutic Society, May I , 1922. U'HER~AS, the exact therapeutic value of new and even old drugs cannot be demonstrated owing to (I) the variety of names under which they are marketed; ( 2 ) the variation in their character, quality and strength due to different processes of manufacture; (3) the opprobrium of publishing in mcdical journals laudatory articles advertising commercially controlled drugs;
π SIMILAR VOLUMES